Trial NCT00809783

View at ClinicalTrials.gov 
Org. Study IDs: A4091016
Secondary IDs: P3 LONG TERM SAFETY EXTENSION

Last trial update was posted on 2021-05-10

MeSH Interventions

Tanezumab

MeSH Conditions

Osteoarthritis

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Due to FDA imposed clinical hold, enrollment was stopped prematurely and, therefore, not all study procedures and visits occurred as planned.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID